Kuzior A, Hernandez-Lazaro A, De Leon-Durango R, Rios-Gomez C, et al. INITIATION OF EMPAGLIFLOZIN THERAPY IS ASSOCIATED WITH A CLINICALLY RELEVANT DECREASE IN BLOOD PRESSURE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND UNCONTROLLED HYPERTENSION. J Hypertens 2022;40.
PMID: 36026663